Showing 1741-1750 of 9096 results for "".
The Value of Radiation as an Option for BCC and SCC
https://practicaldermatology.com/issues/may-june-2025/the-value-of-radiation-as-an-option-for-bcc-and-scc/35919/The Skin Cancer Foundation calls Mohs micrographic surgery the gold standard for treating basal cell carcinomas and squamous cell carcinomas.NIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiNoah Worcester 2024: Dr. Gottlieb on Psoriatic Arthritis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gottlieb-psoriatic-arthritis/24594/Alice Gottlieb, MD, PhD, summarizes her lecture on the critical role of the dermatologist in preventing disability due to psoriatic arthritis at the 2024 Noah Worcester Dermatological Society meeting.Low-Nickel Diets Show Promise for Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-2024/low-nickel-diets-show-promise-for-contact-dermatitis/20256/Matthew Zirwas, MD, discusses his experience with the “low-nickel diet” for patients who have systemic reactions to dietary nickel.What’s New for Treating Hyperhidrosis?
https://practicaldermatology.com/conferences/scale-2023/whats-new-for-treating-hyperhidrosis/20208/The treatment of hyperhidrosis has changed a lot over the years. Larry Green, MD, discusses some of the exciting innovations including targeted alkali thermolysis.Exosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.What to do if your practice’s social accounts are inactive
https://practicaldermatology.com/topics/practice-management/what-to-do-if-your-practices-social-accounts-are-inactive/20127/Social media is the can’t miss marketing platform of 2022. However, it has been around long enough that many businesses have already tried it and given up years ago. If you are among the many dermatology practices with an old, outdated, nearly inactive Facebook or other social accounts, check out thEyeing a Treatment for Syringoma
https://practicaldermatology.com/videos/scientifically-speaking/eyeing-a-treatment-for-syringoma/20112/Listen as Joel L. Cohen, MD describes early evidence for the use of nano pulse stimulation to treat syringoma, a notoriously challenging target.DermWireTV: Dupixent for Kids; Epsolay Launch; Scleroderma Awareness; Chicago Derms Celebrate Diversity
https://practicaldermatology.com/topics/practice-management/dermwiretv-dupixent-for-kids-epsolay-launch-scleroderma-awareness-chicago-derms-celebrate-diversity/20100/Epsolay (benzoyl peroxide 5%) Cream from Galderma is now available for the topical treatment of rosacea. It was developed by Sol-Gel. Dupixent from Sanofi and Regeneron is now the only biologic medicine FDA approved for use from infancy through adulthood for the management of atopic dermatitis. June